The B2B Podcast

This is the first episode in our second season exploring the evolving landscape of real-world data and its role in shaping healthcare decisions.This conversation will provide answers on why the same knee replacement costs dramatically different amounts depending on whether you're in New York City, Minneapolis, or Chicago – and whether moving care to an ambulatory surgery center actually saves money.Not estimates. Not posted prices. Actual commercial allowed amounts, from one of the largest claims databases in the world.Guest are:- Kaitlin Quinn, VP of Data & Analytics at Lantern — a specialty care platform for surgery, infusions and cancer care navigation available through employers - And John Linnehan, VP and Head of Real World Data, Truven  

This podcast explores the technology shifts set to reshape value creation, capital allocation and dealmaking from 2025 to 2035. Produced in association with Sterling Technology, the podcast is aimed at investors, M&A dealmakers and corporate strategists. The episode will also highlight the most important themes driving changes in the world of technology, and the opportunities that come with them. The guest is Isabel Al-Dhahir, Principal Analyst in the Strategic Intelligence division at GlobalData. 

This is the final episode in season one of Insights Uncovered: A Real-World Data Podcast Series from GlobalData, presented by MarketScan®.Episode five explores the evolving landscape of real-world data, brought to you by MarketScan, a Truven Data Solution.You will hear an open discussion on the complexities and experiences with driving meaningful insights from linked data. The guests from MarketScan are: - Liisa Palmer, Portfolio Leader for Real-World Data Research & Analytics- And Rachel Connolly, Senior Director of Alliance Partnerships

Designed for industrials M&A dealmakers and investors, this podcast highlights the most important themes driving major changes reshaping heavy industry across the globe. The conversation covers the key themes dominating industrials: smart industry technologies, structural shifts like Industry 4.0, ESG, M&A intelligence and the macro risk to be aware of. This podcast is sponsored by Sterling Technology - the provider of premium virtual data room solutions for secure sharing of content and collaboration for industrials dealmaking. Hosted by Tom Lawrence and featuring David Bicknell, principal analyst at GlobalData covering the industrials sector.

This is the fourth episode in our series, Insights Uncovered: A Real-World Data Podcast Series, exploring the evolving landscape of real-world data and its role in shaping healthcare decisions.The episode will take a closer look at healthcare access in the United States – a topic that continues to dominate conversations in political, public health, and economic circles. While much of the national dialogue centers on insurance coverage and affordability, the reality is that access to care involves far more than simply having insurance.Also covered in the episode are the policies, data, and real-world factors that influence healthcare access for the 92% of Americans who are insured.Guests are:- Liisa Palmer, Portfolio Leader for Real World Data Research & Analytics at MarketScan- And Katherine Shanahan, Senior Pharmacy Analytic Advisor for Health Insights, Truven’s healthcare analytics platform for payers and employers

Join us for the latest installment of Novotech’s expert podcast, exploring the rapidly evolving world of global obesity clinical trials and the transformative role of GLP-1 therapies.Dr. Stecco is a healthcare executive with 25 years of leadership and medical monitoring experience across the pharmaceutical, biotech, and medical device sectors. A former Chief Medical Officer and consultant to over20 obesity-focused companies, she is also a practicing physician with deep expertise in treating obesity using therapies like GLP-1 receptor agonists, Orlistat, Qsymia, and Contrave. Dr.Stecco holds an MA and MD from the University of Southern California and completed her surgical training at Stanford University Medical Center. Gab is a seasoned clinical research professional with over 20 years of experience across both site and CRO settings. He has held key roles including Senior Study Coordinator, CRA, Project Manager, and Therapeutic Strategy Manager. Gab has significant expertise in Phase I–III clinical trials conducted in Australia and globally, with a strong focus on early-phase research — covering study design, protocol development, regulatory strategy, feasibility, budgeting, and timeline management. He currently leads the Strategy team for the obesity portfolio. Gab holds a Bachelor of Nursing and a Master of Health Sciences in Health Administration.​